Ultra Violette SPF50+ FUTURE FLUID
SPF 50+, broad spectrum, lotion. AUST L 455450, from Grace & Fire Pty Ltd.
Keep using sunscreen. The TGA says its benefits far outweigh any risks, and nothing here says a product is unsafe: the limits are proposals.
Active ingredients
| Ingredient | On the ARTG as | Amount | % |
|---|---|---|---|
| Zinc oxide Mineral | zinc oxide | 200 mg/g | 20% |
Percent by weight: the ARTG gives each active in mg per gram, and 10 mg/g is 1%.
Against the TGA’s proposed limits
This sunscreen lists none of the three filters under review (homosalate, oxybenzone and 4-MBC), so none of the proposed limits would apply to it.
Where this comes from
Everything above is from this product’s entry on the Australian Register of Therapeutic Goods: ARTG 455450, Ultra Violette SPF50+ FUTURE FLUID. We read its public summary on 21 October 2026; the entry dates from 16 July 2024. The name on the shelf can differ from the register’s. If the label shows a different AUST L number, it’s a different formula. Spotted a mistake? Email hello@sunscreenfilters.com.
Worried about an ingredient, or choosing for a baby or someone with sensitive skin? Talk to your doctor or pharmacist.
More from Ultra Violette
- Ultra Violette Fave Fluid SPF 50+ Ensulizole 4%, Avobenzone 3%, Bemotrizinol 2%, Bemotrizinol 2%, Ethylhexyl triazone 1%
- Ultra Violette SPF 50+ Extreme Screen (New Formulation) Homosalate 10%, Octocrylene 8%, Octisalate 5%, Avobenzone 3% Homosalate 10%, above all three TGA proposed limits
- Ultra Violette SPF30 Clean Screen Titanium dioxide 4%, Bisoctrizole 2.5%, DHHB 1.6%
- Ultra Violette SPF50 Vibrant Screen Homosalate 7%, Octisalate 5%, Bemotrizinol 3%, Avobenzone 3%, Ethylhexyl triazone 2%, Ensulizole 1.8% Homosalate 7%, above all three TGA proposed limits
- Ultra Violette SPF50+ Supreme Screen Octinoxate 10%, Bemotrizinol 3%, Bisoctrizole 2.5%